UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~October~~September 199, ~~2012~~2013

RxRX Technologies Corp.

(Exact name of registrant as specified in its charter)

Florida

(State or other jurisdiction

of incorporation)

333-156942

(Commission

File Number)

26-3891952

(IRS Employer

Identification No.)

7076 Spyglass Avenue, Parkland, FL 33076

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (954-) 599-3672

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):


¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~ITEM 4.01 ~~Changes~~CHANGES inIN ~~Registrant~~REGISTRANT’sS ~~Certifying~~CERTIFYING ~~Accountant.~~ACCOUNTANT

(a) ~~Dismissal~~(1) On August 13, 2013, the PCAOB revoked the registration of ~~Independent~~the ~~Registered~~Registrant’s ~~Public~~prior ~~Accounting~~independent ~~Firm~~accountant, Lake & Associates, CPA’s LLC, whose address is 1905 Wright Blvd., Schaumburg, IL 60193 (“Lake”), due to Lake’s violations of PCAOB rules and auditing standards in auditing the financial statements and PCAOB rules and quality control standards with respect to four of Lake’s clients; the Registrant was not one of the clients for which Lake was sanctioned.

On October 19, 2012, Lake & Associates CPA’s LLC (“Lake & Associates”) resigned as the independent registered public accounting firm of the Company. The resignation was accepted by the Board of Directors of the Company (the “Board”).

During the two most recent fiscal years and through the date of this report, there were no (1) disagreements with Lake & Associates on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to its satisfaction would have caused Lake & Associates to make reference in its reports on the Company’s financial statements for such years to the subject matter of the disagreement, or (2) “reportable events,” as such term is defined in Item 304(a)(1)(v) of Regulation S-K.

The audit reports of Lake & Associates on the financial statements of the Company, during the periods from November 15, 2008 through October 19, 2012, did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles, except that the reports stated there is substantial doubt about the Company’s ability to continue as a going concern.

~~The~~We ~~Company~~are ~~has~~in ~~requested that Lake & Associates furnish it with a letter addressed to~~ the ~~Securities~~process ~~and~~of ~~Exchange~~re-auditing ~~Commission~~our ~~stating~~financial ~~whether or not it agrees with the above~~ statements ~~and,~~that ifwould ~~not,~~be ~~stating~~required ~~the~~to ~~respects~~be inincluded ~~which it does not agree. A copy of such letter, dated October 22, 2012, indicating that it is~~ in ~~agreement~~ filings with ~~such~~the ~~disclosures is filed as Exhibit 16~~Commission.~~1 to this Form 8-K.~~

~~(b) Engagement~~On September 9, 2013, the Registrant provided a draft copy of ~~New~~this ~~Independent~~report ~~Registered~~on ~~Public~~Form ~~Accounting~~8-K ~~Firm~~to Lake, requesting their comments on the information contained therein. The responsive letter from Lake is filed as an exhibit to this current report on Form 8-K.

OnITEM ~~October~~9.01 ~~19,~~FINANCIAL ~~2012,~~STATEMENTS ~~the~~AND ~~Board of Directors approved the appointment of MaloneBailey, LLP (“MaloneBailey”) as the independent registered public accounting firm of the Company.~~EXHIBITS

~~During~~(d) Exhibit ~~the~~16.1 ~~Company’s~~- ~~two~~Responsive ~~most~~Letter ~~recent~~from ~~fiscal~~Lake ~~years~~& ~~and the subsequent interim periods preceding MaloneBailey’s engagement~~Associates, neither the Company nor anyone on behalf of the Company consulted with MaloneBailey regarding the application of accounting principles to any specific completed or contemplated transaction, or the type of audit opinion that might be rendered on the CompanyCPA’s financial statements, and MaloneBailey did not provide any written or oral advice that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue or any matter that was the subject of a “disagreement” or a “reportable event,” as such terms are defined in Item 304(a)(1) of Regulation S-KLLC.

~~Item 9.01 Financial Statements and Exhibits.~~SIGNATURES

~~(d)~~Pursuant ~~Exhibits~~to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

The following exhibits are filed with this Current Report on Form 8-K:


Date: September 9, 2013	RX Technologies Corp.

	By:	/s/ Michael P. McManus
		Name: Michael P. McManus
		Title: President

Exhibit No.		Description
16.1		Letter to the Securities and Exchange Commission from Lake & Associates CPA’s LLC, dated October 22, 2012.

- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 22, 2012	Rx Technologies Corp.
	By:	/s/ Michael P. McManus
		Name: Michael P. McManus
		Title: President

- 2 -

Filing Compare · Rx Technologies Corp.